BioCorRx (BICX) Receivables - Other (2016 - 2025)
BioCorRx (BICX) has disclosed Receivables - Other for 10 consecutive years, with $52026.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other changed N/A to $52026.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52026.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $52026.0 for FY2025, N/A changed from the prior year.
- Receivables - Other hit $52026.0 in Q4 2025 for BioCorRx, down from $153728.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $958111.0 in Q2 2022 to a low of $1500.0 in Q1 2021.
- Historically, Receivables - Other has averaged $206359.3 across 5 years, with a median of $84346.0 in 2023.
- Biggest five-year swings in Receivables - Other: skyrocketed 63774.07% in 2022 and later crashed 99.24% in 2023.
- Year by year, Receivables - Other stood at $56359.0 in 2021, then skyrocketed by 117.63% to $122652.0 in 2022, then plummeted by 37.82% to $76266.0 in 2023, then skyrocketed by 311.94% to $314170.0 in 2024, then tumbled by 83.44% to $52026.0 in 2025.
- Business Quant data shows Receivables - Other for BICX at $52026.0 in Q4 2025, $153728.0 in Q2 2025, and $153360.0 in Q1 2025.